Interpace Biosciences IDXG
OTC IDXG
$6.05 -0.20 (-3.20%)
At close: Nov 13, 2026 · 4:00 PM EST

Interpace Biosciences (IDXG) Gains from Sales and Divestitures (2015 - 2021)

Updated

Interpace Biosciences (IDXG) posted Gains from Sales and Divestitures of -$248,000 for Q4 2021.

Analysis

Interpace Biosciences (IDXG) Gains from Sales and Divestitures (2015 - 2021) Analysis & Trends

For FY2021, Interpace Biosciences' Gains from Sales and Divestitures came in at -$13,000.

  • The Q4 2021 figure stands as the highest quarterly Gains from Sales and Divestitures since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn
10 Interpace Biosciences 167.59 Mn 158.32 Mn 5.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -248,000.00
Dec 31, 2015 21.42 Mn
Jun 30, 2015 -68,000.00
Mar 31, 2015 285,000.00
API Access

Interpace Biosciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=IDXG&period=max&api_key=YOUR_API_KEY